- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03527563
Study on Internet Medical Models for the Management of Patients With Hypertension in China
A Comparative Study on Internet Medical Models and Conventional Medical Models for the Management of Patients With Hypertension in China
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Protocol Title:A Comparative Study on Internet Medical Models and Conventional Medical Models for the Management of Patients with Hypertension in China Study Indication:Hypertension Number of Site:16sites Study Duration (from the initiation of the first site to the end of the follow-up for the last subject): 12 months Duration of Treatment and Management: 6 months Planned Number of Subjects:958 subjects, 479 in each group(blood pressure management in Internet medical model, Conventional medical model) Internet Medical Model:Using Internet blood pressure management model: home blood pressure self-monitoring + Internet diagnosis + Maintained or adjusted anti-hypertension drug(s) treatment.
Conventional Medical Model:Using Conventional blood pressure management model: home blood pressure monitoring + face-to-face diagnosis in clinic + Maintained or adjusted anti-hypertension drug(s) treatment.
Inclusion Criteria:
- Male or female, 45 to 75 years old (including 45and 75 years);
- Two measurements of resting systolic blood pressure ≥ 140mmHg and/or diastolic blood pressure ≥ 90mmHg on different days during screening;
Female subjects of child-bearing potential who are willing to adopt one of the following methods for contraception during the study:
- Oral contraceptive, either combined or progestogen alone.
- Injectable progestogen.
- Implants of levonorgestrel.
- Oestrogenic vaginal ring.
- Percutaneous contraceptive patches.
- Intrauterine device or intrauterine system showing that the expected failure rate is less than 1% per year as stated in the product label.
- Double barrier method: condom and an occlusive cap (diaphragm or cervical/vault caps) with a vaginal spermicidal agent (foam/gel/film/cream/suppository).
- Subjects who can understand and perform home blood pressure monitoring as required by the study;
- Subjects who voluntarily participate in the study and sign informed consent form.
Exclusion Criteria:
- Two measurements of resting systolic blood pressure ≥ 180mmHg and/or diastolic blood pressure ≥ 110mmHg on different days during screening;
- Subjects with the history of cerebral stroke within 6 months prior to screening;
- Subjects with the history of myocardial infarction within 6 months prior to screening;
- Subjects with the history of heart failure;
- Subjects with the history of atrial fibrillation;
- Subjects with the history of coronary artery revascularization;
- Subjects with other serious diseases, such as tumor;
- Subjects diagnosed as the secondary hypertension;
- Subjects with congenital or acquired organic heart disease;
- Pregnant or lactant subjects;
- Subjects with severe mental disease;
- Subjects with abnormal liver and renal function: ALT or AST>2 X upper limit value; Or creatinine > 2X upper limit value
- Subjects who were previously diagnosed with diabetes that is currently poorly controlled: FBG>10mmol/L;
- Subjects who are unable to conduct blood pressure self-test;
- The subject has any other known condition at screening that would compromise subject safety, might affect life expectancy, or making it difficult to successfully manage and follow the subject according to the protocol.
Efficacy Evaluations:
Primary Efficacy Endpoints:
- Blood pressure control rate of subjects in the two groups at Month 6 Secondary Efficacy Endpoints:
- Blood pressure control rate of subjects in the two groups at Month 3
- Blood pressure value of subjects in the two groups at Month 3 and Month 6
- Change of blood pressure of subjects in the two groups at Month 3 and Month 6
- Variability of blood pressure of subjects in the two groups at Month 3 and Month 6
- Treatment compliance of subjects in the two groups at Month 3 and Month 6
- Medical expense of subjects in the two groups at Month 3 and Month 6
- Treatment satisfaction of subjects in the two groups at Month 3 and Month 6
Type d'étude
Inscription (Anticipé)
Phase
- N'est pas applicable
Contacts et emplacements
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Male or female, 45 to 75 years old (including 45 and 75 years);
- Two measurements of resting systolic blood pressure ≥140mmHg and/or diastolic blood pressure ≥90mmHg on different days during screening;
Female subjects of child-bearing potential who are willing to adopt one of the following methods for contraception during the study:
Oral contraceptive, either combined or progestogen alone. Injectable progestogen. Implants of levonorgestrel. Oestrogenic vaginal ring. Percutaneous contraceptive patches. Intrauterine device or intrauterine system showing that the expected failure rate is less than 1% per year as stated in the product label.
Double barrier method: condom and an occlusive cap (diaphragm or cervical/vault caps) with a vaginal spermicidal agent (foam/gel/film/cream/suppository).
- Subjects who can understand and perform home blood pressure monitoring as required by the study;
- Subjects who voluntarily participate in the study and sign informed consent form.
Exclusion Criteria:
- Two measurements of resting systolic blood pressure ≥180mmHg and/or diastolic blood pressure ≥110mmHg on different days during screening;
- Subjects with the history of cerebral stroke within 6 months prior to screening;
- Subjects with the history of myocardial infarction within 6 months prior to screening;
- Subjects with the history of heart failure;
- Subjects with the history of atrial fibrillation;
- Subjects with the history of coronary artery revascularization;
- Subjects with other serious diseases, such as tumor;
- Subjects diagnosed as the secondary hypertension;
- Subjects with congenital or acquired organic heart disease;
- Pregnant or lactant subjects;
- Subjects with severe mental disease;
- Subjects with abnormal liver and renal function: ALT or AST>2 X upper limit value; Or creatinine >2 X upper limit value;
- Subjects who were previously diagnosed with diabetes that is currently poorly controlled: FBG>10mmol/L;
- Subjects who are unable to conduct blood pressure self-test;
- The subject has any other known condition at screening that would compromise subject safety, might affect life expectancy, or making it difficult to successfully manage and follow the subject according to the protocol.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Autre: Internet Medical Model
Using Internet blood pressure management model: home blood pressure self-monitoring + Internet diagnosis + Maintained or adjusted anti-hypertension drug(s) treatment.
|
Subjects in the Internet group should upload blood pressure monitoring data at least once per day.
It is highly recommended to upload two pressure monitoring results to capture more blood pressure information.
The warning value of blood pressure set in the cloud database is systolic blood pressure ≥ 180mmHg or ≤ 100mmHg and diastolic blood pressure ≥ 110mmHg or ≤ 60mmHg.
After enrollment, subjects and physicians communicate via telephone or Internet every two weeks until blood pressure is well controlled judged by physician.
Then the frequency of communication will be changed to once a month.
Once there are lacks of blood pressure data in 3 days of each week, or. blood pressure values of the subject exceed the warning value in 2 days of consecutive 3 days, the physician will take the initiative to contact the patient for disease inquiry.
|
Aucune intervention: Conventional Medical Model
Using Conventional blood pressure management model: home blood pressure monitoring + face-to-face diagnosis in clinic + Maintained or adjusted anti-hypertension drug(s) treatment.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Primary endpoint: blood pressure control rate of subjects in the two groups at Month 6
Délai: 6 months
|
Definition of blood pressure control rate is that the percent of subjects with systolic blood pressure <140 mm Hg and diastolic blood pressure < 90 mm Hg
|
6 months
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Publications et liens utiles
Publications générales
- Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D; American Heart Association; American Society of Hypertension; Preventive Cardiovascular Nurses Association. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. J Cardiovasc Nurs. 2008 Jul-Aug;23(4):299-323. doi: 10.1097/01.JCN.0000317429.98844.04.
- Lawes CM, Vander Hoorn S, Rodgers A; International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet. 2008 May 3;371(9623):1513-8. doi: 10.1016/S0140-6736(08)60655-8.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Anticipé)
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecrutementHypertension Essentielle | Hypertension, masquéTaïwan
-
University of Alabama at BirminghamTroy UniversityComplétéHypertension | Hypertension, résistante à la thérapie conventionnelle | Hypertension non contrôlée | Hypertension, blouse blancheÉtats-Unis
-
Centre Chirurgical Marie LannelongueInconnueHypertension pulmonaire thromboembolique chronique et hypertension artérielle pulmonaireFrance
-
Vanderbilt University Medical CenterJohns Hopkins UniversityComplétéHypertension artérielle pulmonaire | Hypertension artérielle pulmonaire idiopathique | Hypertension artérielle pulmonaire associée | Hypertension artérielle pulmonaire héréditaireÉtats-Unis
-
Amsterdam UMC, location VUmcZonMw: The Netherlands Organisation for Health Research and DevelopmentInconnue
-
University of Kansas Medical CenterRecrutementHypertension artérielle pulmonaire | Hypertension pulmonaire | Hypertension pulmonaire thromboembolique chronique | Hypertension pulmonaire due à une cardiopathie gauche | Hypertension pulmonaire, primaire, 4 | Hypertension pulmonaire, primaire, 2 | Hypertension pulmonaire, primaire, 3 | Hypertension... et d'autres conditionsÉtats-Unis
-
University of MinnesotaComplétéPré hypertension | Hypertension non compliquéeÉtats-Unis
-
Assistance Publique - Hôpitaux de ParisActif, ne recrute pasHypertension portale non cirrhotique intrahépatiqueFrance
-
AstraZenecaComplétéHypertension artérielle (hypertension).
-
Zhejiang UniversityInconnueHypertension artérielle pulmonaire idiopathiqueChine
Essais cliniques sur Internet Medical Model
-
Ann & Robert H Lurie Children's Hospital of ChicagoComplétéLa dépression | Adolescent - Problème émotionnelÉtats-Unis
-
Pyoeng Gyun ChoeRésiliéMaladies de la peauCorée, République de
-
Mayo ClinicRecrutementTumeur au cerveauÉtats-Unis
-
Sun Yat-sen UniversityComplétéLa rétinopathie diabétique | DiagnosticChine
-
National Taiwan University HospitalRetiréGlioblastome multiforme | Épendymome anaplasique | Astrocytomes anaplasiques | Oligodendrogliomes anaplasiques | Tumeurs intracrâniennes malignesTaïwan
-
EchosensComplétéObésité morbide | Fibrose du foieFrance
-
Hôpital le VinatierHospices Civils de Lyon; University Hospital, Strasbourg, France; Versailles... et autres collaborateursComplétéTroubles du spectre autistiqueFrance
-
Soterix MedicalGeorgetown University; National Institute of Neurological Disorders and Stroke... et autres collaborateursComplétéAphasie chroniqueÉtats-Unis
-
Georgetown UniversityNational Cancer Institute (NCI)ComplétéTumeur solide adulte non précisée, protocole spécifiqueÉtats-Unis
-
Yuzuncu Yıl UniversityAtaturk UniversityComplété